Endo became Endo Pharmaceuticals Inc. (NASDAQ: ENDP) as a result of a management buyout from DuPont Merck in 1997.   We are a specialty pharmaceutical company engaged in the research, development, sale and marketing of prescription pharmaceuticals used primarily to treat and manage pain.

Our corporate headquarters are located in Chadds Ford, Pennsylvania.

To learn more about Endo, view the Company Overview or the Corporate Profile section of this website.